The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC).
 
James J. Harding
Research Funding - Calithera Biosciences (Inst); Lilly (Inst); Novartis (Inst); Polaris (Inst)
 
Zachary J. Heins
No Relationships to Disclose
 
Louise Catherine Connell
No Relationships to Disclose
 
Tara Soumerai
No Relationships to Disclose
 
Nancy E. Kemeny
No Relationships to Disclose
 
William R. Jarnagin
No Relationships to Disclose
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Gilead Sciences; Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Merrimack; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst); Polaris (Inst); Sanofi (Inst)
 
Ronald P. DeMatteo
No Relationships to Disclose
 
Michael Ian D'Angelica
No Relationships to Disclose
 
Maeve Aine Lowery
No Relationships to Disclose
 
T. Peter Kingham
No Relationships to Disclose
 
Maya Gambarin
No Relationships to Disclose
 
David Michael Hyman
No Relationships to Disclose
 
Michele LY
No Relationships to Disclose
 
Casey R. Hamilton
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I); Roche/Genentech
Research Funding - Taiho Pharmaceutical
 
Nikolaus Schultz
No Relationships to Disclose
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris